Your browser doesn't support javascript.
loading
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
Junker, Daniel; Becker, Matthias; Wagner, Teresa R; Kaiser, Philipp D; Maier, Sandra; Grimm, Tanja M; Griesbaum, Johanna; Marsall, Patrick; Gruber, Jens; Traenkle, Bjoern; Heinzel, Constanze; Pinilla, Yudi T; Held, Jana; Fendel, Rolf; Kreidenweiss, Andrea; Nelde, Annika; Maringer, Yacine; Schroeder, Sarah; Walz, Juliane S; Althaus, Karina; Uzun, Gunalp; Mikus, Marco; Bakchoul, Tamam; Schenke-Layland, Katja; Bunk, Stefanie; Haeberle, Helene; Göpel, Siri; Bitzer, Michael; Renk, Hanna; Remppis, Jonathan; Engel, Corinna; Franz, Axel R; Harries, Manuela; Kessel, Barbora; Lange, Berit; Strengert, Monika; Krause, Gerard; Zeck, Anne; Rothbauer, Ulrich; Dulovic, Alex; Schneiderhan-Marra, Nicole.
Afiliación
  • Junker D; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Becker M; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Wagner TR; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Kaiser PD; Pharmaceutical Biotechnology, University of Tuebingen, Tuebingen, Germany.
  • Maier S; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Grimm TM; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Griesbaum J; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Marsall P; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Gruber J; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Traenkle B; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Heinzel C; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany.
  • Pinilla YT; Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Held J; Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Fendel R; Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Kreidenweiss A; Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Nelde A; German Center for Infection Research, partner site Tuebingen, Tuebingen, Germany.
  • Maringer Y; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • Schroeder S; Institute of Tropical Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Walz JS; German Center for Infection Research, partner site Tuebingen, Tuebingen, Germany.
  • Althaus K; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • Uzun G; Department of Peptide-Based Immunotherapy, University of Tuebingen and University Hospital Tuebingen, Tuebingen, Germany.
  • Mikus M; Department of Internal Medicine, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium, University Hospital Tuebingen, Tuebingen, Germany.
  • Bakchoul T; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Schenke-Layland K; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tuebingen, Tuebingen, Germany.
  • Bunk S; Department of Peptide-Based Immunotherapy, University of Tuebingen and University Hospital Tuebingen, Tuebingen, Germany.
  • Haeberle H; Department of Internal Medicine, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium, University Hospital Tuebingen, Tuebingen, Germany.
  • Göpel S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Bitzer M; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tuebingen, Tuebingen, Germany.
  • Renk H; Department of Peptide-Based Immunotherapy, University of Tuebingen and University Hospital Tuebingen, Tuebingen, Germany.
  • Remppis J; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Engel C; Department of Otorhinolaryngology, Head and Neck Surgery, University of Tuebingen, Tuebingen, Germany.
  • Franz AR; Department of Peptide-Based Immunotherapy, University of Tuebingen and University Hospital Tuebingen, Tuebingen, Germany.
  • Harries M; Department of Internal Medicine, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium, University Hospital Tuebingen, Tuebingen, Germany.
  • Kessel B; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
  • Lange B; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tuebingen, Tuebingen, Germany.
  • Strengert M; Center for Clinical Transfusion Medicine, Tuebingen, Germany.
  • Krause G; Institute of Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany.
  • Zeck A; Center for Clinical Transfusion Medicine, Tuebingen, Germany.
  • Rothbauer U; Center for Clinical Transfusion Medicine, Tuebingen, Germany.
  • Dulovic A; Center for Clinical Transfusion Medicine, Tuebingen, Germany.
  • Schneiderhan-Marra N; Institute of Clinical and Experimental Transfusion Medicine, University Hospital Tuebingen, Tuebingen, Germany.
Clin Infect Dis ; 76(3): e240-e249, 2023 02 08.
Article en En | MEDLINE | ID: mdl-35717657
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Enzima Convertidora de Angiotensina 2 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoglobulina G / Enzima Convertidora de Angiotensina 2 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article